The Medicines and Health products Regulatory Agency (MHRA) has issued a class three medicines recall for AlfaD Capsules of Theramex.
Theramex Ireland Ltd T/A Theramex HQ UK Ltd has informed the MHRA of an issue related to error in the decommissioning of the capsule batches.
“Upon decommissioning at the pharmacy and when scanning the serialised 2D code, the status of packs may report as ‘EXPORT’. Although there is no risk to product quality, any remaining stock should be quarantined and returned,” MHRA has said in the drug alert released on Thursday (October 29).
Product details
AlfaD 0.25 microgram capsules PL 49876/0001
| Batch Number | Expiry Date | Pack Size | First Distributed |
| A04285 | Apr 2022 | 30 | 15 Sep 2020 |
AlfaD 1 microgram capsules PL 49876/0003
| Batch Number | Expiry Date | Pack Size | First Distributed |
| 106389 | Aug 2022 | 30 | 15 Sep 2020 |
AlfaD 0.25 microgram capsules PL 49876/0001
| Batch Number | Expiry Date | Pack Size | First Distributed |
| A04279A | 31 Jan 2022 | 30 | 26 Mar 2020 |
Community pharmacists have been advised to stop supplying the batches immediately and quarantine all remaining stock and return it to the concerned supplier using their supplier’s approved process.
